Five‐year retrospective review of guideline‐based management of fungal endophthalmitis
Open Access
- 22 July 2008
- journal article
- review article
- Published by Wiley in Acta Ophthalmologica
- Vol. 86 (5), 525-532
- https://doi.org/10.1111/j.1600-0420.2007.01097.x
Abstract
Purpose: Guidelines were introduced in 2000 at the Bristol Eye Hospital (BEH) for the management of fungal endophthalmitis. A 5‐year retrospective audit re‐evaluated the guidelines and monitored the management of this rare condition. Clinical effectiveness and management costs were considered in light of visual outcome. Methods: Cases were identified through a 5‐year retrospective review of theatre logbooks, Patient Administration System coded admissions with primary diagnosis of purulent endophthalmitis and pharmacy logbooks of patients receiving antifungal therapy. Data correlation and review of patient management were carried out in light of the findings. Results: Twenty‐three cases were included, based on clinical disease and/or positive smears or cultures. Age range was 13–74 years, with a male : female ratio of 16 : 7 and right eye : left eye ratio of 14 : 9. Risk factors for fungal endophthalmitis included septicaemia caused by intravenous drug use (78%), presence of indwelling lines (9%), postocular surgery (9%) and post‐trauma (4%). Guidelines were rigidly followed in 56% of cases, with improved visual acuity in 9/13 patients compared to 4/10 where management deviated from guidelines. Deviation from guidelines occurred with incomplete use of the recommended drug regimen for the disease severity or use of drugs that were alternative to the suggested guidelines. Treatment was initiated on clinical judgement in 91% of cases and laboratory diagnosis in 9%. Conclusion: The BEH guidelines provided a useful reference when managing this uncommon condition. Voriconazole, a newer broad‐spectrum agent with good ocular penetration (used in 9%), has been added to the revised guidelines. Monitoring rare conditions over prolonged time frames supports evidence‐based medicine.Keywords
This publication has 13 references indexed in Scilit:
- Posaconazole for treatment of refractory invasive fungal diseaseMycoses, 2006
- ANALYSIS OF PREDISPOSING CLINICAL AND LABORATORY FINDINGS FOR THE DEVELOPMENT OF ENDOGENOUS FUNGAL ENDOPHTHALMITISRetina, 2001
- Use of polymerase chain reaction in the diagnosis of fungal endophthalmitisOphthalmology, 2001
- Fungal and Parasitic Infections of the EyeClinical Microbiology Reviews, 2000
- Use of PCR in endophthalmitisOcular Immunology and Inflammation, 2000
- INTRAOPERATIVE ACETAZOLAMIDE IN THE PREVENTION OF INTRAOCULAR PRESSURE RISE AFTER PARS PLANA VITRECTOMY WITH FLUID-GAS EXCHANGERetina, 1999
- MICROBIOLOGIC YIELDS AND COMPLICATION RATES OF VITREOUS NEEDLE ASPIRATION VERSUS MECHANIZED VITREOUS BIOPSY IN THE ENDOPHTHALMITIS VITRECTOMY STUDYRetina, 1999
- Current and Emerging Azole Antifungal AgentsClinical Microbiology Reviews, 1999
- International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal InfectionsClinical Infectious Diseases, 1997
- Endogenous Candida EndophthalmitisOphthalmology, 1990